{"id":191013,"date":"2018-02-27T04:07:05","date_gmt":"2018-02-27T04:07:05","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=191013"},"modified":"2018-02-27T04:07:05","modified_gmt":"2018-02-27T04:07:05","slug":"does-aipt-have-significant-upside-take-a-look","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/does-aipt-have-significant-upside-take-a-look_191013.html","title":{"rendered":"Does AIPT Have Significant Upside? Take a Look…"},"content":{"rendered":"
Precision Therapeutics, Inc. Projects 10x Sales in 2018 of it’s Streamway System in the United States Alone. Precision Medicine is an emerging field of healthcare that considers a patient\u2019s genes, lifestyle, and environment in the development of effective therapies to treat disease. This is leading to better and more personalized treatments and diagnostic technologies and is rapidly becoming seen as a credible new approach to healthcare.<\/div>\n

\"PRECISION<\/a><\/span><\/p>\n

PRECISION THERAPEUTICS, INC. (formerly Skyline Medical Inc)
Ticker: AIPT 
https:\/\/www.Skylinemedical.com<\/a><\/p>\n

WHO WE ARE:<\/strong><\/p>\n

Precision Therapeutics (NASDAQ:AIPT)<\/strong> operates in two business areas: first, development of a healthcare CRO that provides personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, and second, production of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal.<\/p>\n

The STREAMWAY system minimizes human intervention in operations, it makes the operating room more streamlined and saves hospitals money. Additionally, it reduces environmental waste associated with 50 million disease-infected canisters that are dumped into landfills annually in the US.<\/p>\n

KEY AIPT INVESTMENT POINTS:<\/strong><\/p>\n

* An FDA Approved product in the STREAMWAY System
* AIPT projected that they would sell 100 systems in 2018 in the US alone. This would represent growth of 900% over 2017 and it would nearly double the number of systems they have sold inception to date.
* A business model which offers highly profitable margins
* The company also generates recurring revenues
* The Market Size is estimated to be $2Bil – $3Bil
* There are over 51 Million inpatient procedures performed in the U.S. alone (CDC, National Hospital Discharge Survey)
* The hospital operating room market is large as well with approximately 40,000 operating rooms just in the U.S.
* AIPT’s worldwide distribution network is growing<\/p>\n

WHAT IS PRECISION MEDICINE?<\/strong><\/p>\n

Precision Medicine is an emerging field of healthcare that considers a patient’s genes, lifestyle, and environment in the development of effective therapies to treat disease. This is leading to better and more personalized treatments and diagnostic technologies and is rapidly becoming seen as a credible new approach to healthcare. <\/p>\n

According to research from Global Market Insights, the precision medicine market is estimated to grow at 10.5% CAGR to reach $96 billion by 2024.<\/strong><\/p>\n

PRECISION THERAPEUTICS, INC. (formerly Skyline Medical Inc)
Ticker: AIPT<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> PublicWire
Contact Person:<\/strong> Dave Donlin
Email:<\/strong> ddonlin@publicwire.com
Phone:<\/strong> 4074906635
Address:<\/strong>5850 TG Lee Blvd, Suite 300
City:<\/strong> Orlando
State:<\/strong> FL
Country:<\/strong> United States
Website:<\/strong> http:\/\/publicwire.com<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Precision Therapeutics, Inc. Projects 10x Sales in 2018 of it’s Streamway System in the United States Alone. Precision Medicine is an emerging field of healthcare that considers a patient\u2019s genes, lifestyle, and environment in the development of effective therapies to … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-191013","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/191013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=191013"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/191013\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=191013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=191013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=191013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}